Author Question: Why have transitions become more complicated for contemporary presidents? A)The president has ... (Read 45 times)

fbq8i

  • Hero Member
  • *****
  • Posts: 527
Why have transitions become more complicated for contemporary presidents?
 
  A)The president has more down time between election and inauguration, which allows an opportunity for political resistance to develop.
  B)The president's duties are simpler overall, but the number of duties has greatly increased in recent years.
  C)The president has more political responsibilities, which prevents him or her from attending to other transition details.
  D)Presidents have far more transition responsibilities, and the time in which to complete them has decreased.

Question 2

Theodore Roosevelt's extensive public relations campaign to drum up support for rate regulation among voters is an example of which presidential ability?
 
  A)the bully pulpit
  B)executive orders
  C)the vesting clause
  D)executive privilege



jordangronback

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

D

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library